Morningstar
•
Jul 10, 2026
BioNTech SE: BioNTech Earnings: Clinical Development on Track, Busy Schedule for the Remainder of the Year
Summary
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Market Digest: DG, HPE, PTON, SNOW
Sep 04, 2026
•
DG, SNOW, PTON, HPE
Analyst Report: Peloton Interactive Inc
Sep 04, 2026
•
PTON
VIR: Raising target price to $12.00
Sep 02, 2026
•
VIR
Analyst Report: Zoom Communications Inc
Sep 01, 2026
•
ZM
Market Digest: XEL, KHC, ZM
Sep 01, 2026
•
ZM, KHC, XEL
